-+ 0.00%
-+ 0.00%
-+ 0.00%

Jaguar Health Announces New Patent Issued In Hong Kong For Napo Pharmaceuticals' Crofelemer In Treating Short Bowel Syndrome And Related Conditions

Benzinga·08/19/2024 14:07:26
Listen to the news

Jaguar Supports Proof-Of-Concept Studies For Rare Disease Indications With Results Expected By End Of 2024 And 2025